The standard of care for treating head lice.4
At a time when decades-old OTC formulations are no longer effective due to head lice resistance1, 7 out of 10 pediatric specialists prescribe Spinosad Topical Suspension 0.9% (spinosad).2
Learn MoreEvolve Your Practice with Spinosad Topical Suspension 0.9%.
Today, every practice needs a solution that effectively treats resistant head lice, while assisting you with changing protocols and patient demands:
No known resistance to the active compound, spinosad, in head lice3
Reference(s)
- Gellatly KJ, Krim S,Palenchar DJ, et al. Expansion of the knockdown resistance frequency map for human head lice (phthiraptera: pediculidae) in the United States using quantitative sequencing. Journal of Medical Entomology, 2016:1-7.
- IQVIA: June 11, 2021.
- Spinosad Technical Bulletin Dow AgroSciences LLC (Now Corteva agriscience), Form No. Y45-000-001 (01/01) CBK.
- Spinosad Topical Suspension 0.9% Prescribing Information.
SPN-RRW1-002